321 related articles for article (PubMed ID: 20060303)
21. Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents.
Pan L; Jiang Y; Liu Z; Liu XH; Liu Z; Wang G; Li ZM; Wang D
Eur J Med Chem; 2012 Apr; 50():18-26. PubMed ID: 22326144
[TBL] [Abstract][Full Text] [Related]
22. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
23. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy.
Cheng YJ; Liu ZY; Liang HJ; Fang CT; Zhang NN; Zhang TY; Yan M
Molecules; 2019 May; 24(10):. PubMed ID: 31137832
[TBL] [Abstract][Full Text] [Related]
24. Ring-substituted quinolines as potential anti-tuberculosis agents.
Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
[TBL] [Abstract][Full Text] [Related]
25. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
27. [Active drugs against Mycobacterium tuberculosis].
Coll P
Enferm Infecc Microbiol Clin; 2009 Oct; 27(8):474-80. PubMed ID: 19766360
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
[TBL] [Abstract][Full Text] [Related]
29. [Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
Waisser K; Cizmárik J; Drazková K; Kaustová J
Ceska Slov Farm; 2002 May; 51(3):140-4. PubMed ID: 12058355
[TBL] [Abstract][Full Text] [Related]
30. Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Copp BR; Christiansen HC; Lindsay BS; G Franzblau S
Bioorg Med Chem Lett; 2005 Sep; 15(18):4097-9. PubMed ID: 16005211
[TBL] [Abstract][Full Text] [Related]
31. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
32. Antitubercular activity of new coumarins.
Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
35. Novel linear diamine disubstituted polycyclic 'cage' derivatives as potential antimycobacterial candidates.
Onajole OK; Sosibo S; Govender P; Govender T; van Helden PD; Maguire GE; Mlinarić-Majerski K; Wiid I; Kruger HG
Chem Biol Drug Des; 2011 Dec; 78(6):1022-30. PubMed ID: 21920029
[TBL] [Abstract][Full Text] [Related]
36. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569
[TBL] [Abstract][Full Text] [Related]
37. [Derivatives of phenylcarbamic acid as potential antituberculotics].
Waisser K; Cizmárik J
Ceska Slov Farm; 2012 Feb; 61(1-2):17-20. PubMed ID: 22536648
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
39. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
40. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]